Skip to content

Author

Amar K. Das

We have 2 of 21 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Abstract A158: Racial and ethnic variation in conversion from actionable Guardant360 results to matched targeted therapy in non–small cell lung cancer: A real-world analysis

Although racial and ethnic disparities in genomic testing access are well documented in non–small cell lung cancer (NSCLC), it remains unknown whether disparities persist downstream in the conversion from an actionable result to matched targeted therapy. This step involves only patients who have already been test...

Anya D. Khan, Jie-Min Liao, Amar K. Das et al. · 0 citations
Review Jul 2026

Abstract A025: Real-World Data–Driven Target Discovery in Advanced NSCLC

This work demonstrates the novel application and value of multimodal liquid-biopsy RWD for scalable, clinically anchored therapeutic Target ID in solid tumors and indicates a complementary discovery paradigm that accelerates hypothesis generation grounded in patient outcomes.

Aaron Hardin, Peili Zhang, Amar K. Das · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.